These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10378876)

  • 1. Regulation of VIP production and secretion by murine lymphocytes.
    Martinez C; Delgado M; Abad C; Gomariz RP; Ganea D; Leceta J
    J Neuroimmunol; 1999 Jan; 93(1-2):126-38. PubMed ID: 10378876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 alpha and tumor necrosis factor-alpha differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells.
    Eskay RL; Eiden LE
    Endocrinology; 1992 Apr; 130(4):2252-8. PubMed ID: 1372239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages.
    Martínez C; Delgado M; Pozo D; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Leukoc Biol; 1998 May; 63(5):591-601. PubMed ID: 9581803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex.
    Xin Z; Tang H; Ganea D
    J Neuroimmunol; 1994 Oct; 54(1-2):59-68. PubMed ID: 7929804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid cell subpopulations containing vasoactive intestinal peptide in the rat.
    Leceta J; Martinez MC; Delgado M; Garrido E; Gomariz RP
    Peptides; 1994; 15(5):791-7. PubMed ID: 7984496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP.
    Tang H; Sun L; Xin Z; Ganea D
    Ann N Y Acad Sci; 1996 Dec; 805():768-78. PubMed ID: 8993475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes.
    Gomariz RP; Leceta J; Garrido E; Garrido T; Delgado M
    Regul Pept; 1994 Feb; 50(2):177-84. PubMed ID: 8190917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide in thymus: synthesis, receptors and biological actions.
    Delgado M; Martinez C; Leceta J; Gomariz RP
    Neuroimmunomodulation; 1999; 6(1-2):97-107. PubMed ID: 9876240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIP gene expression in rat thymus and spleen.
    Gomariz RP; Delgado M; Naranjo JR; Mellström B; Tormo A; Mata F; Leceta J
    Brain Behav Immun; 1993 Dec; 7(4):271-8. PubMed ID: 8280921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of vasoactive intestinal peptides on TNF-alpha-induced IL-6 synthesis in osteoblasts: amplification of p44/p42 MAP kinase activation.
    Natsume H; Tokuda H; Mizutani J; Adachi S; Matsushima-Nishiwaki R; Minamitani C; Kato K; Kozawa O; Otsuka T
    Int J Mol Med; 2010 May; 25(5):813-7. PubMed ID: 20372827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages.
    de la Fuente M; Delgado M; del Rio M; Garrido E; Leceta J; Hernanz A; Gomariz RP
    Peptides; 1994; 15(7):1157-63. PubMed ID: 7854966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages.
    Xin Z; Sriram S
    J Neuroimmunol; 1998 Aug; 89(1-2):206-12. PubMed ID: 9726844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.
    Wang HY; Xin Z; Tang H; Ganea D
    J Immunol; 1996 May; 156(9):3243-53. PubMed ID: 8617946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C; Delgado M; Gomariz RP; Ganea D
    J Immunol; 1996 Jun; 156(11):4128-36. PubMed ID: 8666779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The migration of peritoneal cells towards the gut.
    Sminia T; Soesatyo M; Ghufron M; Thepen T
    Adv Exp Med Biol; 1995; 371A():61-5. PubMed ID: 8526001
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasoactive intestinal polypeptide stimulates the proliferation of HaCaT cell via TGF-alpha.
    Sung KJ; Chang SE; Paik EM; Lee MW; Choi JH
    Neuropeptides; 1999 Dec; 33(6):435-46. PubMed ID: 10657522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Neuroimmunol; 1999 May; 96(2):167-81. PubMed ID: 10337915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effects of vasoactive intestinal peptide on intestinal lesions induced by endotoxic shock in rat].
    Zhang YC; Yang LP; Tang DH; Zhang YM
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):369-73. PubMed ID: 16780716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.